The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: To review emerging data on the relationship between lipoprotein(a) and oxidized phospholipids. RECENT FINDINGS: We have recently proposed that a unique physiological role of lipoprotein(a) may be to bind and transport proinflammatory oxidized phospholipids and that this interaction may mediate a common biological influence on cardiovascular disease. In a large series of clinical studies performed to date, a very strong correlation was found between plasma levels of lipoprotein(a) and the content of oxidized phospholipids on apolipoprotein B-100 particles (OxPL/apoB), measured by monoclonal antibody E06, which binds the phosphocholine head group of oxidized phospholipids but not native phospholipids. The correlation of OxPL/apoB to lipoprotein(a) is very strong in individuals with small apolipoprotein(a) isoforms (r = approximately 0.95) and modest in individuals with large isoforms (r = approximately 0.60). In-vitro studies have demonstrated that the vast majority of oxidized phospholipids detected by E06 are bound to lipoprotein(a) in human plasma. A similarly strong association with oxidized phospholipids was also documented in transgenic mice overexpressing lipoprotein(a), even in mice not fed atherogenic diets or with overt atherosclerosis. SUMMARY: A better understanding of the ability of human lipoprotein(a) to bind oxidized phospholipids may allow clinically important insights into the role of oxidized phospholipids and lipoprotein(a) in human athero…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo, circulating Ox-PLs are mostly carried by the lipoprotein(a) (Lp(a)) fraction,46”
From Calcific aortic stenosis (2016) · cites this paper as [46]
Citations
Cites
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Self-citationcDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,372
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
Self-citationEhara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.15.1955 · Cited by 781
Binder, C. J., Hörkkö, S., Dewan, A., Chang, M.-K., Kieu, E. P., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., & Silverman, G. J. (2003) · Nature Medicine · doi:10.1038/nm876 · Cited by 737
Self-citationNavab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Shaw, P. X., Hörkkö, S., Chang, M.-K., Curtiss, L. K., Palinski, W., Silverman, G. J., & Witztum, J. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8472 · Cited by 676
Self-citationInnate and acquired immunity in atherogenesis
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642
Self-citation
Cited by
Items 101–138 of 138
Liu, F., & Cai, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1577762 · Cited by 6
“Accumulation of reactive oxygen species (ROS) promoted the transformation of LDL to oxidized LDL (OxLDL) and the transformation of Lp(a) to oxidized phospholipids (OxPL), which have been proven to facilitate the osteogenic differentiation of VIC in vitro study (Figure 2 Panel 2) (50, 51).”
Atallah, Harb, T., Nasrallah, N., Jones, S. R., Gerstenblith, G., Tsimikas, S., & Leucker, T. M. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120469 · Cited by 5
Self-citationLipoprotein(a): An update on its role in human health and disease
Koutsogianni, A.-D., Liberopoulos, E. N., & Tselepis, A. D. (2021) · Journal of Atherosclerosis Prevention and Treatment · doi:10.53590/japt.02.1028 · Cited by 5
Edelstein, C., Pfaffinger, D., Reichert, E. C., Stafforini, D. M., & Scanu, A. M. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11125339 · Cited by 5
“Considering our observation that Plg is the major oxPtdPC carrier in the circulation, contrary to an early belief [15], we may speculate that Plg modulates OxPtdPC metabolism in the circulation, in physiological and possibly pathological settings.”
Correlations of serum magnesium with dyslipidemia in patients on maintenance hemodialysis
Tony, E. E., Tohamy, M., Amin, N. F., Abdel-Aal, A. M., & Rahim, S. (2017) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/1110-9165.207900 · Cited by 5
Groenen, A. G., Matveyenko, A., Matienzo, N., Halmos, B., Zhang, H., Westerterp, M., & Reyes‐Soffer, G. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117474 · Cited by 5
“Smaller APO (a) isoforms correlate with high Lp(a) plasma levels and have high affinity for oxidized phospholipids (oxPL) [12–14].”
Rybicka, M., Seroka, A., Obrębski, M., Chwiejczak, J., Górny, A., Kościan, J., Młynarska, J., Szczerkowska, K., Wójcik, A., & Mitkowska, M. (2024) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.212 · Cited by 3
“Even though Lp(a) serum concentration is genetically determined, several studies have shown a correlation between its concentration and inflammation [89].”
BackgroundNegative Risk Markers for Cardiovascular Risk Evaluation in Chinese Adults
Bie, L., Niu, J., Wu, S., Zheng, R., Xu, M., Lu, J., Wang, T., Zhao, Z., Wang, S., Lin, H., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.800671 · Cited by 3
“However, high levels of lipoprotein(a) with its OxPL load recirculating into the vasculature may turn into harm (16).”
BackgroundPhysiological Roles and Functions of Lipoprotein(a)
Safiullah, Z. N., Leucker, T. M., Jones, S. R., & Toth, P. P. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-24575-6_8 · Cited by 3
Mass Spectrometry‐Based Platforms for Protein Lipoxidation Profiling
Tang, Z., Wang, T., & Liu, C. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202402062 · Cited by 3
Zheng, D., & Cui, C. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109136 · Cited by 2
Lipidomics in Atherosclerotic Vascular Disease
Jänis, M. T., & Laaksonen, R. (2012) · Wiley eBooks · doi:10.1002/9783527655946.ch13 · Cited by 2
Cesaro, A., Scherillo, G., Michele, G. D., Acerbo, V., Signore, G., Panico, D., Porcelli, G., Scialla, F., Raucci, G., Rotolo, F. P., et al. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.35 · Cited by 1
Li, Y., Wang, H., & Zhang, Y.-Y. (2025) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2025.12.002 · Cited by 1
Hsu, H., Fan, H., Tsai, M.-C., Lai, C.-J., Hwang, L. C., & Chien, K. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-0847 · Cited by 3
Chapman, M. J., Thérond, P., & Meikle, P. J. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109050 · Cited by 1
Lipoprotein (a) and Cardiovascular Risk
Peromingo, J. A. D. (2012) · InTech eBooks · doi:10.5772/31174 · Cited by 1
“This issue confers a greater opportunity to Lp(a) oxidation (21) and interaction of Lp(a) with macrophages (22,23).”
Statins and Mipomersen: Mechanisms of Action and Patient Tolerability
Pang, J., Chan, D. C., & Watts, G. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-20433-8_7 · Cited by 1
“The atherogenicity of Lp(a) may, in part, be mediated by oxidised phospholipids, which associate with small apo(a) isoforms [ 14 ].”
BackgroundRelation Between Red Cell Distribution Width and Serum Lipoprotein(a) in Healthy Adult Men
Çelik, A., & Kılınç, M. (2016) · Clinical & Medical Biochemistry Open Access · doi:10.4172/2471-2663.1000120 · Cited by 1
“Lp(a) carries cholesterol and transports the more atherogenic proinflammatory oxidized phospholipids, which attract inflammatory cells to vessel walls and leads to smooth muscle cell proliferation, thus contributes to atherosclerosis [4,5,8].”
BackgroundLipoprotein(a) – es wird Zeit, das Dornröschen wach zu küssen
Kronenberg, F. (2017) · Praxis · doi:10.1024/1661-8157/a002761 · Cited by 1
Oxidized phospholipids modify plasminogen and apolipoprotein(a): Implications for vascular disease
Scanu, A. M., Stafforini, D. M., & Edelstein, C. (2012) · American Journal of Molecular Biology · doi:10.4236/ajmb.2012.22012
“A number of studies in an apparently unrelated line of investigations have pointed at the contribution of oxidized phospholipids (oxPL), and particularly oxidized phosphatidylcholines (oxPC), to the pathogenesis of cardiovascular disease [6,7].”
BackgroundAPOLIPROTEIN(A)-INDUCED APOPTOSIS IN VASCULAR ENDOTHELIAL CELLS
Tra, J. (2011) · QSpace (Queen's University Library)
Autoxidation of Plasma Lipids, Generation of Bioactive Products, and Their Biological Relevance
Kuksis, A., & Pruzanski, W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-63067-044-3.50014-5
Jordanov, M. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-11161-2_2
“All these features of Lp(a) cause generation of clots, atherosclerosis which consequently leads to coronary artery disease [21] It is found that in isolated homogeneous tribal population of Tanzania, vegetarians have higher levels of Lp(a) than fish eaters.”
BackgroundInfluentialBilir, B. E., Bilir, B., & Takır, M. (2016) · Medeniyet Medical Journal · doi:10.5222/mmj.2016.046
Feric, N. T. (2011) · QSpace (Queen's University Library)
The Clinical Utility of Genetic Risk Scores Following Myocardial Infarction
Northcott, H. (2016) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17061737
Lipoprotein(a) and the risk of vascular disease
Erqou, S. A. (2010) · Apollo (University of Cambridge) · doi:10.17863/cam.16247
Millar, J. S., & Rader, D. J. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-24575-6_4
Approach to the Patient with Lipid Disorders
Lee, K. M. S., & Yassine, H. N. (2015) · Springer eBooks · doi:10.1007/978-3-319-11161-2_6
Taylor, P. (2013) · Otago University Research Archive (University of Otago)
Koutsogianni, A. D., Barkas, F., Tellis, C. C., Tselepis, A. D., Liamis, G. L., Tsimikas, S., & Liberopoulos, E. N. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02896-5
“Indeed, Lp(a) carries a disproportionately high content of oxidized phospholipids (OxPLs), particularly on its apolipoprotein(a) moiety, which colocalizes with apoB on the LDL-like particle [16–18].”
InfluentialSelf-citationMyagmarsuren, M., Law, H. G., Zhang, W., Bang, H., Bishop, L. M., Shen, T., Fiehn, O., Petersen, K. S., Berglund, L., & Enkhmaa, B. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101032
“These OxPL subspecies were selected due to their associations with Lp(a)/apo(a) (19, 22) and contributions to Lp(a) atherogenicity via enhancing arterial inflammation (21, 23).”
Khan, M. A., Myagmarsuren, M., Zhang, W., Law, H. G., Sanchez, M., Roshanravan, B., Bang, H., Bishop, L. M., Shen, T., Fiehn, O., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.05.225
Wang, Z., Sun, B., Wang, W., Xiong, T., & Wei, G. (2026) · Journal of Medical Biochemistry · doi:10.5937/jomb0-67129
Ma, X., Jiang, J., Wei, Y., Lan, C., Su, B., Liu, X., Tian, R., Lv, Z., Wang, X., Hu, A., et al. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.09.019
Metadata
- Authors
- Tsimikas, S., & Witztum, J. L.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Tsimikas, Sotirios
- Venue
- Current Opinion in Lipidology
- Published
- 2008-08
- Volume
- 19
- Issue
- 4
- Pages
- 369-377
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W1998280774
- Cited by
- 138
- References
- 53
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 7 · 2020: 2 · 2019: 5 · 2018: 2 · 2017: 7 · 2016: 11 · 2015: 12 · 2014: 9 · 2013: 7 · 2012: 10
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- lipoprotein(a), oxidized phospholipids, atherogenicity, apolipoprotein B-100, apolipoprotein(a) isoforms, atherosclerosis, cardiovascular disease, transgenic mice
- MeSH terms
- Animals, Apolipoproteins B, Humans, Oxidation-Reduction, Phospholipids, Risk, Lipoprotein(a), Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.